Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry
Background: There is limited data from large naturalistic studies to inform prescribing of long-acting injectable medication (LAIs). Guidance is particularly rare in the case of primary mood disorders. Methods: This study describes prescribing trends of LAIs in 3879 patients in Quebec, Canada, over...
Saved in:
Main Authors: | Emmanuel Stip (Author), Syed Javaid (Author), Jonathan Bayard-Diotte (Author), Karim Abdel Aziz (Author), Danilo Arnone (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19
by: Emmanuel Stip, et al.
Published: (2020) -
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies
by: Francesco Bartoli, et al.
Published: (2023) -
Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
by: Joanna Moncrieff, et al.
Published: (2020) -
Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024) -
Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis
by: Zina Sherzad Qadir, et al.
Published: (2023)